| Labcorp Women's Health

April 28, 2025

Prenatal Testing: The Importance of Early Preeclampsia and Genetic Screening in Pregnancy

Early preeclampsia and genetic screening in pregnancy can identify conditions that may increase risk for fetal and maternal complications. Insights from these screenings can help your patients better prepare for the future.In our webinar, you'll learn how early preeclampsia screening and the latest developments in cell-free DNA (cfDNA) noninvasive prenatal testing (NIPT) can help you improve maternal and perinatal outcomes.

December 1, 2024

Utilization of a SNP microarray to detect uniparental disomy: Implications and outcomes

Authors

Alexandra Arreola, Gloria Haskell, Inder Gadi, Andrea Penton, Stuart Schwartz

March 20, 2025

Multiple Deletions In Chromosome 13 Mediated By Chromothripsis: A Case Report

Authors

Zach Ou, MD; Judith Knops, PhD; Deanna Hutchinson, MS; Inder Gadi, PhD; Bing Huang, PhD

March 20, 2025

Understanding prenatal chromosomal abnormalities; importance of both chromosomal and microarray aberrations

Authors

Bob Best, PhD; Alexandra Arreola, PhD; Inder Gadi, PhD; Gloria Haskell, PhD; Bing Huang, PhD; Judith Knops, PhD; Andrea Penton, PhD; Karen Phillips, PhD; James Tepperberg, PhD; Stuart Schwartz, PhD

March 20, 2025

Examination of prenatal cases referred for uniparental disomy 16: Referral patterns, positive associations and key findings

Authors

Andrea Penton, PhD; Alexandra Arreola, PhD; Inder Gadi, PhD; Gloria Haskell, PhD; Karen Phillips, PhD; Amanda Sussman, PhD; James Tepperberg, PhD; Stuart Schwartz, PhD

March 20, 2025